LinkPeptide
![Smac/Diablo Peptide [AVPIAQKSE], 5-FAM labeled](https://www.linkpeptide.com/wp-content/uploads/2026/05/Smac-Diablo-Peptide-AVPIAQKSE-5-FAM-labeled.jpg "Smac/Diablo Peptide [AVPIAQKSE], 5-FAM labeled")
Get a Quote
Get a Quote
LinkPeptide provides high quality catalog peptides with different purity at highly competitive prices. Our catalog peptides are supported by our unparalleled experience in peptide synthesis. We have nearly 10 years experience in synthesizing peptides, LinkPeptide is the premier supplier of high quality peptides to leading biotechnology companies and academic institutions.
8
years of trusted peptide supply
Providing high-quality bioactive peptides, inhibitors, and custom peptide synthesis for pharmaceutical and academic research.
High-quality peptides for research, drug discovery, and cosmetic applications, 8+ years of peptide synthesis expertise,
End-to-end solutions from custom synthesis to large-scale production, flexible support for diverse research needs
8+ years of peptide synthesis expertise: Where proven quality meets advanced technologies for modern life science research.
LinkPeptide delivers high-quality catalog peptides with multiple purity options at competitive prices. Our products are backed by extensive experience in peptide synthesis and strict quality control standards.
With nearly a decade of expertise, LinkPeptide is a trusted partner for biotechnology companies and academic institutions, supporting research in drug discovery, molecular biology, and cosmetic science.
LinkPeptide provides high quality catalog peptides with different purity at highly competitive prices. Our catalog peptides are supported by our unparalleled experience in peptide synthesis. We have nearly 10 years experience in synthesizing peptides, LinkPeptide is the premier supplier of high quality peptides to leading biotechnology companies and academic institutions.
State-of-the-art production site supporting scalable peptide synthesis, from research-grade batches to large-scale manufacturing.
SPPS Synthesis Laboratory Equipped with advanced solid-phase peptide synthesis (SPPS) platforms, enabling precise, efficient, and high-throughput peptide productio
SPPS Synthesis Laboratory
Equipped with advanced solid-phase peptide synthesis (SPPS) platforms, enabling precise, efficient, and high-throughput peptide production.
Integrated Production Workflow
Seamless transition from synthesis to purification and analysis, ensuring fast turnaround and reproducible, high-quality peptide products.
HPLC & Mass Spectrometry
High-performance liquid chromatography (HPLC) and MS systems for purity analysis, identity confirmation, and batch consistency verification.
Microneedling, traditionally viewed as a cosmetic procedure, is now emerging as a powerful therapeutic tool in dermatology. By creating controlled micro-injuries in the skin, it triggers collagen and elastin production while enhancing the delivery of topical agents into deeper layers. This review-based blog explores microneedling’s expanding cl…
Details
Plecanatide, a guanylate cyclase-C (GC-C) agonist, has gained attention as an effective treatment for chronic idiopathic constipation (CIC), a condition that can significantly diminish patients’ quality of life. By mimicking uroguanylin, a natural ligand, Plecanatide activates GC-C receptors in a pH-dependent way, encouraging bowel fluid secret…
Non-viral gene delivery has emerged as a promising alternative to viral vectors, offering advantages in safety, scalability, and payload flexibility. Yet despite major progress in lipid nanoparticles and synthetic carriers, one fundamental biological hurdle continues to limit its effectiveness: DNA must reach the nucleus to be expressed. A rece…
Peptide-based immune checkpoint inhibitors (ICIs) are emerging as a promising alternative to monoclonal antibodies and small-molecule inhibitors in cancer immunotherapy. These peptides effectively disrupt immune checkpoint interactions, such as PD-1/PD-L1, TIGIT/PVR, and LAG-3/MHC-II, to restore antitumor immune responses. Recent advancements i…